American Addiction Centers (AAC) has announced an important shift in leadership with the promotion of Dr. David Hans and Ellen-Jo Boschert to the roles of co-CEOs. This significant addiction treatment leadership change comes after nearly two years under the guidance of Dr. Tom Britton, who has now departed from his position as CEO. This new leadership marks a pivotal moment for AAC, signaling the company’s continued commitment to providing high-quality addiction treatment while navigating the growing demand for these essential services.
Dr. David Hans: A Proven Leader in Addiction Treatment
Dr. David Hans takes on the role of co-CEO after serving as the Chief Clinical and Compliance Officer at AAC. His experience in healthcare leadership, especially in addiction treatment, makes him a key figure in this addiction treatment leadership change. Before joining AAC, Dr. Hans held CEO positions at Haven Behavioral Hospital in Albuquerque and Acadia Healthcare’s Life Healing Center. His diverse background in clinical care and organizational management positions him perfectly to lead AAC during this crucial transition.
In his statement regarding the addiction treatment leadership change, Dr. Hans expressed his enthusiasm: “We look forward to continuing to work closely with our facilities and employees across the organization to strengthen AAC’s position as a leading addiction treatment provider, especially at a time when more people are in need of high-quality behavioral healthcare.”
Ellen-Jo Boschert: A Key Player in the Leadership Transition
Ellen-Jo Boschert, who joined AAC in 2022 as Chief Operating Officer, is another integral part of this addiction treatment leadership change. Boschert has been instrumental in overseeing the company’s patient care operations and strategic direction. With her vast experience as a healthcare operations leader, Boschert’s role in the company will be vital in maintaining AAC’s reputation for providing excellent patient care.
Boschert’s leadership style has been focused on innovation, improving patient outcomes, and ensuring that the organization adapts to the evolving healthcare landscape. Her role in AAC’s growth since 2022 has made her the perfect choice to co-lead the company in this period of leadership transition. She expressed her excitement about the future of AAC in a statement, noting, “I am excited to help guide AAC into its next chapter, and I’m committed to continuing our work to provide the highest level of care for those in need of addiction treatment.”
Commitment to Clinical Excellence Amid Leadership Change
This addiction treatment leadership change also marks a renewed focus on AAC’s core values: clinical excellence, patient-centered care, and innovation. Bowen Diehl, Chairman of the AAC Board of Directors, praised the decision to appoint Dr. Hans and Boschert as co-CEOs, saying, “Ellen-Jo and Dr. Hans possess the knowledge, passion, and expertise to continue building upon our commitment to clinical excellence and our mission to provide life-changing care.”
AAC has long been recognized as one of the nation’s top addiction treatment providers, and with this leadership transition, the company remains steadfast in its commitment to offering evidence-based treatment, cutting-edge therapies, and comprehensive support to those affected by addiction.
A History of Resilience and Rebuilding
Founded in 2007, AAC operates 10 locations across eight states. The company has faced its share of challenges, including being delisted from the New York Stock Exchange in 2019 and filing for bankruptcy in 2020. Despite these financial hurdles, AAC underwent a successful Chapter 11 restructuring and emerged stronger. The leadership change, with the promotion of Dr. Hans and Boschert, reflects the company’s resilience and its determination to rebuild and grow.
The leadership change within AAC is a clear signal of the company’s commitment to overcoming its past difficulties and advancing its mission to provide high-quality addiction treatment. With the new leadership team in place, AAC is ready to continue expanding its reach and improving the care it provides to individuals and families affected by addiction.
Looking Forward: AAC’s Vision for the Future
As AAC moves forward under the leadership of Dr. Hans and Boschert, the company is focused on expanding its services and increasing its capacity to meet the growing demand for addiction treatment. This addiction treatment leadership change is a significant step in AAC’s journey, ensuring that the company remains a leader in the field of addiction recovery.
The need for addiction treatment services is greater than ever, and AAC’s leadership team is committed to meeting that demand with top-tier care, compassion, and expertise. Dr. Hans and Boschert are poised to continue AAC’s legacy of providing life-changing care to those seeking recovery from addiction, all while navigating the ever-changing landscape of addiction treatment.
A Renewed Focus on Growth and Patient Care
The addiction treatment leadership change within AAC is more than just a shift in titles; it’s about continuing to build a foundation for long-term success. Under the guidance of Dr. Hans and Boschert, AAC is prepared to strengthen its clinical offerings, expand its treatment options, and continue providing support to individuals in need of addiction recovery. As leaders in the field of addiction treatment, they are committed to making a lasting difference in the lives of those affected by substance use disorders.
As AAC begins this new chapter, the leadership of Dr. Hans and Boschert will undoubtedly shape the future of the organization, ensuring that AAC remains at the forefront of addiction treatment, delivering life-changing care to people across the country.
